Gadolinium-based Contrast Agent
- Name
- Gadolinium-based Contrast Agent
- Accession Number
- DBCAT003476
- Description
Not Available
- Drugs
Drug Drug Description Gadobutrol A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadolinium cation (3+) Not Annotated Gadoversetamide A gadolinium compound used as a contrast agent in MRI tests of the brain, spine, and liver. Gadobenic acid A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadofosveset trisodium An intravenous contrast agent used during magnetic resonance angiography (MRA) to evaluate aortoiliac occlusive disease (AIOD) in adults with peripheral vascular disease. Gadoxetic acid A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize the liver. Gadoteric acid A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. Gadopiclenol A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. - Drugs & Drug Targets